Status:
COMPLETED
PED NEONAT 20-000599 Fetal Body Composition
Lead Sponsor:
University of California, Los Angeles
Conditions:
IUGR
Gestational Diabetes
Eligibility:
FEMALE
18+ years
Phase:
PHASE1
Brief Summary
Obesity is an ongoing public health problem that is difficult to treat. There is evidence that obesity has fetal origins. Body composition, including visceral, subcutaneous, brown, and hepatic fat hav...
Detailed Description
1.1 OBJECTIVE This study's goals are to: 1) use free-breathing magnetic resonance imaging (FB-MRI) to measure fetal body composition in the third trimester and 2) determine how the FB-MRI quantitative...
Eligibility Criteria
Inclusion
- Pregnant women with singleton pregnancies (healthy cohort)
- Pregnant women with fetuses with weights \< 10th percentile weight for gestational age (IUGR cohort)
- Pregnant women with gestational diabetes (diabetes cohort)
Exclusion
- Pregnant minors
- Major congenital anomalies or disease processes in the fetus
- Fetus with known chromosomal anomalies
- Mothers who do not plan to deliver at UCLA
- Multiple pregnancy (i.e. twins, triplets, etc)
- History of claustrophobia
- Contraindications to MRI such as metallic devices in the body that are not MRI compatible
Key Trial Info
Start Date :
August 17 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 18 2022
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT04508751
Start Date
August 17 2020
End Date
May 18 2022
Last Update
August 30 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California-Los Angeles
Los Angeles, California, United States, 90095
2
University of California- Los Angeles Santa Monica
Santa Monica, California, United States, 90404